Remote Ischemic Conditioning in Cardiovascular Surgery: Still a Viable and Realistic Option?

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 22, Issue 4, 2017, Pages 297-301

  Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

cardioprotection; ischemic heart disease; myocardial ischemia; reperfusion

Indexed keywords

PROPOFOL; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ACUTE HEART INFARCTION; ANESTHESIA; CARDIOVASCULAR SURGERY; COMORBIDITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; INTRAVENOUS ANESTHESIA; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NEEDS ASSESSMENT; NONHUMAN; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; BLOOD FLOW; CARDIAC MUSCLE; HEART INFARCTION; HEART SURGERY; PATHOLOGY; PROCEDURES; PROTECTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VASCULAR SURGERY;

ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CARDIAC SURGICAL PROCEDURES; COMORBIDITY; HUMANS; ISCHEMIC PRECONDITIONING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROPOFOL; PROTECTIVE FACTORS; REGIONAL BLOOD FLOW; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 85020472205     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248416687874     Document Type: Review

References (36)

1. Heusch G, Botker HE, Przyklenk K, Redington A, Yellon DM,. Remote ischemic conditioning. J Am Coll Cardiol. 2015; 65 (2): 177-195.
2. Heusch G,. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post- and remote conditioning. Circ Res. 2015; 116 (4): 674-699.
3. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P,. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87 (3): 893-899.
4. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002; 106 (23): 2881-2883.
5. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ,. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans. Role of the autonomic nervous system. J Am Coll Cardiol. 2005; 46 (3): 450-456.
6. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. Lancet. 2007; 370 (9587): 575-579.
7. Heusch G, Rassaf T,. Time to give op on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res. 2016; 119 (5): 676-695.
8. Candilio L, Malik A, Ariti C, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015; 101 (3): 185-192.
9. Thielmann M, Kottenberg E, Kleinbongard P, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013; 382 (9892): 597-604.
10. Hausenloy DJ, Candilio L, Evans R, et al.ERICCA Trial Investigators. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015; 373 (15): 1408-1417.
11. Heusch G, Gersh BJ,. ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! Eur Heart J. 2016; 37 (2): 200-202.
12. Samanta A, Dawn B,. Remote Ischemic Preconditioning for Cardiac Surgery: Reflections on Evidence of Efficacy. Circ Res. 2016; 118 (7): 1055-1058.
13. Garratt KN, Whittaker P, Przyklenk K,. Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart. Circ Res. 2016; 118 (7): 1052-1054.
14. Sloth AD, Schmidt MR, Munk K, et al.CONDI Investigators. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J. 2014; 35 (3): 168-175.
15. Kleinbongard P, Neuhäuser M, Thielmann M, et al. Confounders of cardioprotection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting. Cardiology. 2016; 133 (2): 128-133.
16. Zaugg M, Lucchinetti E, Behmanesh S, Clanachan AS,. Anesthetic cardioprotection in clinical practice from proof-of-concept to clinical applications. Curr Pharm Des. 2014; 20 (36): 5706-5726.
17. Zangrillo A, Musu M, Greco T, et al. Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: A Bayesian Network meta-analysis of randomized trials. PLoS One. 2015; 10 (7): e0134264.
18. Kottenberg E, Thielmann M, Bergmann L, et al. Protection by remote ischaemic preconditioning during coronary artery bypass grafting with isoflurane but not with propofol anesthesia-a clinical trial. Acta Anaesthesiol Scand. 2012; 56 (1): 30-38.
19. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G,. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014; 147 (1): 376-382.
20. Bautin AE, Galagudza MM, Datsenko SV, et al. Effects of remote ischemic preconditioning on perioperative period in elective aortic valve replacement [in Russian]. Anesteziol Reanimatol. 2014;(3): 11-17.
21. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M,. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans. Circ Res. 2012; 110 (1): 111-115.
22. Neukom L, Vastani N, Seifert B, Spahn DR, Maurer K,. Propofol decreases the axonal excitability in rat primary sensory afferents. Life Sci. 2012; 90 (9-10): 343-350.
23. McDougall SJ, Bailey TW, Mendelowitz D, Andresen MC,. Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS). Neuropharmacology. 2008; 54 (3): 552-563.
24. Wang X, Huang ZG, Gold A, et al. Propofol modulates gamma-aminobutyric acid-mediated inhibitory neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Anesthesiology. 2004; 100 (5): 1198-1205.
25. Mastitskaya S, Marina N, Gourine A, et al. Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res. 2012; 95 (4): 487-494.
26. Donato M, Buchholz B, Rodriguez M, et al. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning. Exp Physiol. 2013; 98 (2): 425-434.
27. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R,. Interaction of risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014; 66 (4): 1142-1174.
28. Ma LL, Kong FJ, Guo JJ, et al. Hypercholesterolemia abrogates remote ischemic preconditioning-induced cardioprotection: Role of reperfusion injury salvage kinase signals. Shock. 2017; 47 (3): 363-369.
29. Kleinbongard P, Heusch G,. Extracellular signalling molecules in the ischaemic/reperfused heart-druggable and translatable for cardioprotection? Br J Pharmacol. 2015; 172 (8): 2010-2025.
30. Kottenberg E, Thielmann M, Kleinbongard P, et al. Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand. 2014; 58 (4): 453-462.
31. Sloth AD, Schmidt MR, Munk K, et al.CONDI Investigators. Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial. BMJ Open. 2015; 5 (4): e006923.
32. Meybohm P, Bein B, Brosteanu O, et al.RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015; 373 (15): 1397-1407.
33. Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E,. Nitroglycerin does not interfere with protection by remote Ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther. 2013; 27 (4): 359-361.
34. Hamarneh A, Sivaraman V, Bulluck H, et al. The Effect of Remote Ischemic Conditioning and Glyceryl Trinitrate on Perioperative Myocardial Injury in Cardiac Bypass Surgery Patients: Rationale and Design of the ERIC-GTN Study. Clin Cardiol. 2015; 38 (11): 641-646.
35. Heusch G, Gersh BJ,. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017; 38 (11): 774-784.
36. Zarbock A, Schmidt C, Van Aken H, et al.RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015; 313 (21): 2133-2141.